The report provides a detailed analysis essential for establishing an otilonium bromide production plant. It encompasses all critical aspects necessary for otilonium bromide production, including the cost of otilonium bromide production, otilonium bromide plant cost, otilonium bromide production costs, and the overall otilonium bromide production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating an otilonium bromide production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.
Otilonium Bromide is a pharmaceutical compound mainly used in the treatment of gastrointestinal disorders. It is widely utilised as an antispasmodic drug for the treatment of gastrointestinal disorders, particularly irritable bowel syndrome (IBS). It works by relaxing the smooth muscles of the digestive tract, which helps reduce abdominal pain, intestinal cramps, and discomfort caused by spasms. It is also used to manage symptoms such as bloating, irregular bowel movements, and digestive disturbances associated with functional bowel disorders. In addition, it is often utilised in the formulation of tablets and other oral medications designed to improve gut motility and relieve spasmodic pain in the digestive tract. It is mainly used as a drug to provide relief from spasmodic disorders of the stomach and intestines. Moreover, it is also used to manage spasms in the gastrointestinal tract and improve overall digestive function. It also plays an important role in reducing excessive intestinal contractions without significantly affecting normal digestion.
The primary factor that drives the market for otilonium bromide is its demand as a spasmolytic agent for the management of irritable bowel syndrome and related digestive conditions. Its application as an antimuscarinic for the treatment of IBS symptoms like abdominal pain, bloating, and motility issues by relaxing gut muscles significantly boosts its demand in the pharmaceutical industry. Its usage as an oral medication for controlling symptoms such as bloating, discomfort, and irregular bowel movements also contributes to its demand in the medical and pharmaceutical industries.
Its involvement as a component in the formulation of drugs designed to regulate intestinal motility and improve overall digestive function further boosts its demand in the pharmaceutical production and healthcare industries. Its demand in several therapeutic preparations aimed at managing chronic digestive conditions and improving patient comfort also drives its market expansion. Additionally, industrial otilonium bromide procurement is influenced by factors such as raw material availability, production costs, and adherence to regulatory and quality standards. Technological improvements in synthesis methods, supplier reliability, sustainable production practices, and efficient distribution channels also play a crucial role in shaping global procurement trends and supply chain dynamics.
Raw Material for Otilonium Bromide Production
According to the otilonium bromide production plant project report, the major raw materials for otilonium bromide production include o-octyloxybenzoyl chloride and 2-diethylaminoethyl p-aminobenzoate.
Production Process of Otilonium Bromide
The extensive otilonium bromide production cost report consists of the following industrial production process:
- Production via Chemical Synthesis: The production process of otilonium bromide begins with the reaction of o-octyloxybenzoyl chloride with 2-diethylaminoethyl p-aminobenzoate in an aqueous medium under continuous stirring. During the addition, an alkaline environment is maintained by gradually adding sodium hydroxide solution to control the reaction and promote the formation of the benzoylated intermediate. Then, the reactants are added slowly to ensure proper mixing and controlled conversion. After the addition is complete, the mixture is stirred further to allow the reaction to finish and the product to form as a solid precipitate. The precipitate is then separated from the reaction mixture, dried, and purified through recrystallisation, followed by quaternisation with a brominating agent to obtain otilonium as the desired product.
Otilonium Bromide is a quaternary ammonium salt and belongs to the class of anticholinergic and antispasmodic compounds. It appears as a white to off-white powder and is practically insoluble in water at room temperature. However, it can dissolve slightly in warm water at a concentration of approximately 5 mg/ml. The molecular formula of the compound is C29H43BrN2O4, and its molar mass is 563.58 g/mol. Its melting point ranges between 130–133 degrees Celsius, and it is recommended to be stored at −20 degrees Celsius to maintain stability. The compound exhibits slight solubility in organic solvents such as DMSO and methanol. When heated to decomposition, it emits toxic fumes of bromine and nitrogen oxides. The compound is classified as a skin and eye irritant and is moderately toxic by ingestion and subcutaneous routes. It is recommended to exercise caution in patients with glaucoma, prostatic hypertrophy, or pyloric stenosis, as well as pregnant or lactating women, when handling or using this compound.